AAAAAA

   
Results: 1-8 |
Results: 8
Antiangiogenic strategies in pancreatic cancer
Authors: Bruns, CJ Ellis, LM Radinsky, R
Citation: Cj. Bruns et al., Antiangiogenic strategies in pancreatic cancer, MD AND SOIL, 2002, pp. 357-367
Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha
Authors: Ozawa, S Shinohara, H Kanayama, H Bruns, CJ Bucana, CD Ellis, LM Davis, DW Fidler, IJ
Citation: S. Ozawa et al., Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha, NEOPLASIA, 3(2), 2001, pp. 154-164
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms
Authors: Bruns, CJ Harbison, MT Davis, DW Portera, CA Tsan, R McConkey, DJ Evans, DB Abbruzzese, JL Hicklin, DJ Radinsky, R
Citation: Cj. Bruns et al., Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms, CLIN CANC R, 6(5), 2000, pp. 1936-1948
Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma
Authors: Inoue, K Slaton, JW Perrotte, P Davis, DW Bruns, CJ Hicklin, DJ McConkey, DJ Sweeney, P Radinsky, R Dinney, CPN
Citation: K. Inoue et al., Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma, CLIN CANC R, 6(12), 2000, pp. 4874-4884
Inhibition of tumor growth and metastasis of human melanoma by intracellular anti-ATF-1 single chain Fv fragment
Authors: Jean, D Tellez, C Huang, SY Davis, DW Bruns, CJ McConkey, DJ Hinrichs, SH Bar-Eli, M
Citation: D. Jean et al., Inhibition of tumor growth and metastasis of human melanoma by intracellular anti-ATF-1 single chain Fv fragment, ONCOGENE, 19(22), 2000, pp. 2721-2730
Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma
Authors: Bruns, CJ Solorzano, CC Harbison, MT Ozawa, S Tsan, R Fan, D Abbruzzese, J Traxler, P Buchdunger, E Radinsky, R Fidler, IJ
Citation: Cj. Bruns et al., Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma, CANCER RES, 60(11), 2000, pp. 2926-2935
Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages
Authors: Bruns, CJ Shinohara, H Harbison, MT Davis, DW Nelkin, G Killion, JJ McConkey, DJ Dong, ZY Fidler, IJ
Citation: Cj. Bruns et al., Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages, CANCER RES, 60(1), 2000, pp. 2-7
Vascular endothelial growth factor is an in vivo survival factor for tumorendothelium in a murine model of colorectal carcinoma liver metastases
Authors: Bruns, CJ Liu, WB Davis, DW Shaheen, RM McConkey, DJ Wilson, MR Bucana, CD Hicklin, DJ Ellis, LM
Citation: Cj. Bruns et al., Vascular endothelial growth factor is an in vivo survival factor for tumorendothelium in a murine model of colorectal carcinoma liver metastases, CANCER, 89(3), 2000, pp. 488-499
Risultati: 1-8 |